Oncology wounds – recommendations for care based on multidisciplinary cooperation
Authors:
S. Vokurka 1; A. Pokorná 2,3; J. . Stryja 4; L. Krupová 5; V. Mezera 6; J. Cvek 7; P. Holečková 8; R. Ston 9; L. Hašková 10; M. Audyová 11; Z. Pechačová 8; S. Šípová 1; K. Jirsová 12; L. Veverková 13
Authors‘ workplace:
Onkologická a radioterapeutická klinika LF v Plzni UK a FN Plzeň
1; Ústav zdravotnických věd, LF MU Brno
2; Institut bio statistiky a analýz, LF MU Brno
3; Salvatella s. r. o., Třinec
4; Kožní oddělení, FN Ostrava
5; Geriatrické centrum, Pardubická nemocnice
6; Klinika onkologická LF OU a FN Ostrava
7; Ústav radiační onkologie 1. LF UK a FN Bulovka, Praha
8; Chirurgické oddělení, Nemocnice Na Františku, Praha
9; MOÚ Brno
10; Diecézní charita Brno, Dům léčby bolesti s hospicem sv. Josefa, Rajhrad
11; Integrované onkologické centrum, Nemocnice Na Pleši
12; I. chirurgická klinika LF MU a FN u sv. Anny v Brně
13
Published in:
Klin Onkol 2022; 35(5): 408-420
Category:
Short Communication
doi:
https://doi.org/10.48095/ ccko2022408
Overview
Background: Oncology wounds and wounds of other etiology are rare but serious complications, which significantly impair patients‘ quality of life. Preventive and curative interventions and education of healthcare personnel and patients reduce the risk of either their occurrence or their impact and consequences. A working group of authors from professional groups (the Supportive Care Group of the Czech Society for Oncology, the Czech Society for Wound Healing, the Society for Radiation Oncology, Biology and Physics, and the Czech Nurses Association) prepared recommendations for care. A comprehensive approach to the treatment of oncological wounds, including symptomatic treatment of associated healing complications, prevention, early detection, interdisciplinary cooperation and education are essential to deal with wounds related to chemotherapy administration, radiotherapy and oncological treatment in general. The proper choice of local care products and the eventuality of active oncological treatment are important elements of care in ulcerating tumors. Purpose: A basic summary of recommended interventions to prevent and treat oncology wounds in daily practice, defined based on expert societies guidelines, trials and literature data, proven practice and on the consensus opinions of the author‘s group members. The recommended procedures contribute to the reduction of the development, severity and consequences of oncological wounds and wounds of other etiology in oncological patients.
Keywords:
nursing – Chemotherapy – radiotherapy – oncology – wound care – malignant tumor – wound – exulceration
Sources
1. Taberna M, Gil Moncayo F, Jané-Salas E et al. The multidisciplinary team (MDT) approach and quality of care. Front Oncol 2020; 10: 85. doi: 10.3389/fonc.2020.00085.
2. Tautenhahn J, Jannasch O, Lippert H. Wunde, Wundheilung, Wundbehandlung. Allegemeine Visceralchirurgie 2007; 3: 201–216.
3. Isoherranen K, O’Brien JJ, Barker J et al. Atypical wounds. Best clinical practice and challenges. J Wound Care 2019; 28 (Suppl 6): S1–S92. doi: 10.12968/jowc.2019.28. Sup6.S1.
4. Woo KY, Sibbald RG. Local wound care for malignant and palliative wounds. Adv Skin Wound Care 2010; 23 (9): 417–428. doi: 10.1097/01.ASW.0000383206.322 44.e2.
5. Česká společnost pro léčbu rány. Doporučené léčebné postupy. [online]. Dostupné z: https: //www.cslr.cz/Informace-pro-praxi/Doporucene-lecebne-postupy/.
6. Vokurka S, Maňásek V, Navrátilová Hrabánková D et al. Extravasation (paravasation) of chemotherapy drugs – updated recommendations (2020) for standard care in the Czech Republic from the cooperation of the Supportive Care Group of the Czech Society for Oncology, Czech Society for Hematology, Oncology Section of the Czech Nurses Association and the Society for Ports and Permanent Catheters. Klin Onkol 2020; 33 (5): 390–395. doi: 10.14735/amko2020390.
7. Cvek J, Vokurka S, Hajnová Fukasová E et al. Recommendation for preventive and therapeutic skin care of patients undergoing radiotherapy. Klin Onkol 2021; 34 (6): 481–487. doi: 10.48095/ccko2021481.
8. Schulz V, Kozell K, Biondo PD et al. The malignant wound assessment tool: a validation study using a Delphi approach. Palliat Med 2009; 23 (3): 266–273. doi: 10.1177/0269216309102536.
9. da Costa Santos CM, de Mattos Pimenta CA, Nobre MR. A systematic review of topical treatments to control the odor of malignant fungating wounds. J Pain Symptom Manage 2010; 39 (6): 1065–1076. doi: 10.1016/j.jpainsymman.2009.11.319.
10. Kirchberger MC, Erfurt-Berge C. Management of malignant wounds. Z Gerontol Geriatr 2020; 53 (6): 572–576. doi: 10.1007/s00391-019-01629-w.
11. Misciali C, Dika E, Fanti PA et al. Frequency of malignant neoplasms in 257 chronic leg ulcers. Dermatol Surg 2013; 39 (6): 849–854. doi: 10.1111/dsu.12168.
12. Combemale P, Combemale P, Debure C et al. Malignancy and chronic leg ulcers: the value of systematic wound biopsies: a prospective, multicenter, cross-sectional study. Arch Dermatol 2012; 148 (6): 704–708. doi: 10.1001/archdermatol.2011.3362.
13. Probst S, Arber A, Faithfull S. Malignant fungating wounds: a survey of nurses‘ clinical practice in Switzerland. Eur J Oncol Nurs 2009; 13 (4): 295–298. doi: 10.1016/j.ejon.2009.03.008.
14. Wang K, Tepper JE. Radiation therapy-associated toxicity: etiology, management, and prevention. CA Cancer J Clin 2021; 71 (5): 437–454. doi: 10.3322/caac.21689.
15. Al-Hilli Z, Wilkerson A. Breast surgery: management of postoperative complications following operations for breast cancer. Surg Clin North Am 2021; 101 (5): 845–863. doi: 10.1016/j.suc.2021.06.014.
16. Moore Z. Managing wounds as a team-development of a universal model for the team approach to wound care. Int J Integrated Care 2014; 14 (6). doi: 10.5334/ijic. 1695.
17. Pokorná A. Ošetřovatelství v geriatrii: hodnotící nástroje. Praha: Grada 2013.
18. Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md State Med J 1965; 14: 61–65.
19. Norton D. Calculating the risk: reflections on the Norton Scale. Decubitus 1989; 2 (3): 24–31.
20. Gadd MM, Morris SM. Use of the Braden Scale for pressure ulcer risk assessment in a community hospital setting: the role of total score and individual subscale scores in triggering preventive interventions. J Wound Ostomy Continence Nurs 2014; 41 (6): 535–538. doi: 10.1097/WON.0000000000000066.
21. LeBlanc K, Baranoski S, Christensen D et al. International skin tear advisory panel: a tool kit to aid in the prevention, assessment, and treatment of skin tears using a Simplified Classification System©. Adv Skin Wound Care 2013; 26 (10): 459–476. doi: 10.1097/01.ASW.0000434056.04071.68.
22. Hematology & Oncology. The management of psychological issues in oncology. [online]. Dostupné z: https: //www.hematologyandoncology.net/archives/december-2016/the-management-of-psychological-issues-in-oncology/.
23. Nersesyan H, Slavin KV. Current aproach to cancer pain management: availability and implications of different treatment options. Ther Clin Risk Manag 2007; 3 (3): 381–400.
24. Společnost pro léčbu závislosti na tabáku. Doporučený postup léčby závislosti na tabáku 2022. [online]. Dostupné z: https: //www.slzt.cz/doporucene-postupy.
25. Státní ústav pro kontrolu léčiv. Souhrn údajů o pří- pravku (SPC), Caelyx. [online]. Dostupné z: https: //www. sukl.cz/modules/medication/detail.php?code=0027 432&tab=texts.
26. Vokurka S, Hugo J. Moderní molekuly v onkologii. Praha: Maxdorf 2019.
27. Modrá kniha České onkologické společnosti. Doporučení pro léčbu kožních změn v důsledku terapie inhibitory EGFR. [online]. Dostupné z: https: //www.linkos.cz/lekar-a-multidisciplinarni-tym/personalizovana-onkologie/modra-kniha-cos/aktualni-vydani-modre-knihy/27-34-doporuceni-pro-lecbu-koznich-zmen-v-dusledku-terapie-inhibitory-egfr/.
28. Stryja J. Repetitorium hojení ran 2. Praha: Geum 2011.
29. European Wound Management Association (EWMA). Position document: wound bed preparation in practice. London: MEP Ltd 2004.
30. Atkin L, Bućko Z, Conde Montero E et al. Implementing TIMERS: the race against hard-to-heal wounds. J Wound Care 2019; 23 (Suppl 3a): S1–S50. doi: 10.12968/jowc.2019.28.Sup3a.S1.
31. Pramod S. A soft silicone foam dressing that aids healing and comfort in oncology care. Br J Nurs 2021; 30 (1): 40–46. doi: 10.12968/bjon.2021.30.1.40.
32. Davies P, McCarty S, Hamberg K. Silver-containing foam dressings with Safetac: a review of the scientific and clinical data. J Wound Care 2017; 26 (Suppl 6a): S1–S32. doi: 10.12968/jowc.2017.26.Sup6a.S1.
33. Firmino F, Villela-Castro DL, Santos JD et al. Topical management of bleeding from malignant wounds caused by breast cancer: a systematic review. J Pain Symptom Manage 2021; 61 (6): 1278–1286. doi: 10.1016/j.jpainsymman.2020.10.020.
34. Ambrogio RI, Levine MH. Tranexamic acid as a hemostatic adjunct in dentistry. Compendium 2018; 39 (6).
35. Aboud C, Pimenta C, Nobre M. A systematic review of topical treatments to control the odor of malignant fungating wounds. J Pain Symptom Manage 2010; 39 (6): 1065–1076. doi: 10.1016/j.jpainsymman.2009.11. 319.
36. Bates-Jensen BM, Seaman S, Early L. Skin disorders: tumor necrosis, fistulas and stomas. In: Ferrell BR, Coyle N (eds). Textbook of palliative nursing. Oxford University Press 2010: 329–343.
37. Woo KY, Sibbald RG. Local wound care for malignant and palliative wounds. Adv Skin Wound Care 2010; 23 (9): 417–428. doi: 10.1097/01.ASW.0000383206.32244.e2.
38. Tsichlakidou A, Govina O, Vasilopoulos G et al. Intervention for symptom management in patients with malignant fungating wounds – a systematic review. J BUON 2019; 24 (3): 1301–1308.
39. Oh D, Son D, Kim J et al. Freeze-dried bovine amniotic membrane as a cell delivery scaffold in a porcine model of radiation-induced chronic woundsv. Arch Plast Surg 2021; 48 (4): 448–456. doi: 10.5999/aps.2020.00997.
40. Pichlsberger M, Dragin Jerman U, Obradović H et al. Systematic review of the application of perinatal derivatives in animal models on cutaneous wound healing. Front Bioeng Biotechnol 2021; 9: 742858. doi: 10.3389/fbioe.2021.742858.
41. Lia K, Jacobson MB, Johnson RD et al. Impaired wound healing after radiation therapy: a systematic review of pathogenesis and treatment. JPRAS Open 2017; 13: 92–105. doi: 10.1016/J.JPRA.2017.04.001.
42. Regulski M, Danilkovitch A, Saunders M. Management of a chronic radiation necrosis wound with lyopreserved placental membrane containing viable cells. Clin Case Rep 2019; 7 (3): 456–460. doi: 10.1002/ccr3. 2011.
43. Yang X, Ren H, Guo X et al. Radiation-induced skin injury: pathogenesis, treatment, and management. Aging (Albany NY) 2020; 12 (22): 23379–23393. doi: 10.18632/aging.103932.
Labels
Paediatric clinical oncology Surgery Clinical oncologyArticle was published in
Clinical Oncology
2022 Issue 5
Most read in this issue
- Gastrointestinal toxicity of systemic oncology immunotherapy
- Patient’s benefi ts from physician’s empathy and results of including of empathy development into medical training
- Oncology wounds – recommendations for care based on multidisciplinary cooperation
- Exercise as a tool to improve the quality of life of patients after breast cancer treatment